Discover 743 paid clinical trials in British Columbia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 743
Active & Responsive
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
for
Cervical Cancer,
Location: Vancouver, Portland OR, Edmonton, Clovis CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT04895709
Phase1, Phase2, Recruiting
Active & Responsive
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Kelowna, Vancouver, Vancouver WA, Portland OR,
Sponsor: Celgene
Sex: Male
Age: 18+
Code: NCT06764485
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)
for
Alzheimer Disease, Dementia
Location: Kelowna, Bellevue WA, Portland OR, Sherman Oaks CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 55 - 70+
Code: NCT06721156
Phase2, Recruiting
Active & Responsive
Mobile Health to Enhance Exercise in Type 2 Diabetes
for
Diabetes Mellitus, Type 2, Telemedicine, Mobile Applications,
Location: Kelowna
Sponsor: University of British Columbia
Sex: All
Age: 40 - 70+
Code: NCT04653532
Recruiting
Active & Responsive
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Kelowna, Spokane WA, Victoria, Berkeley CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136559
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors
for
Solid Tumor
Location: Vancouver, Denver CO, Chicago IL, Grand Rapids MI,
ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
for
Myelodysplastic Syndromes
Location: Vancouver, Kennewick WA, Calgary, Walnut Creek CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05949684
Phase3, Recruiting
Active & Responsive
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)